Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

A man developed skin issues from cancer medication, which improved with specific treatments.

The new drug delivery system effectively targets lung cancer cells.

Finasteride is a medicine used to treat enlarged prostate and prostate cancer, and it works by changing how testosterone works in the body.

Finasteride can cause a unique skin reaction on the penile shaft.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

Finasteride caused blisters on hands and feet.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Oral tofacitinib successfully treated total body hair loss in one patient.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Antiretrovirals can affect finasteride's effectiveness, so dose adjustments may be needed for men on HIV treatment.